{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:47:42Z","timestamp":1770353262243,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Psychiatry at the Warren Alpert Medical School of Brown University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The present study investigates the relationship between cognitive performance, depression, anxiety, and factors of medical burden (i.e., polypharmacy, medical comorbidities, disease duration, disability level, and self-reported fatigue level) in a population of multiple sclerosis (MS) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective investigation was conducted with data collected from 106 MS patients (87 female; 19 male) referred to an outpatient, hospital-based neuropsychology clinic. Participants underwent a comprehensive neuropsychological evaluation, which included measures of attention, processing speed, executive functioning, language, motor function, visuospatial abilities, and memory, as well as self-report assessments of depression, anxiety, and fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After correcting for multiple comparisons, bivariate pairwise correlations revealed positive relationships between number of medications and depression scores, Fatigue Questionnaire scores and depression scores, and Fatigue Questionnaire scores and trait anxiety scores. Hierarchical regression analysis showed that greater scores on the Fatigue Questionnaire predicted lower attention composite scores independent of participants\u2019 age or education. No significant relationships between psychiatric factors and cognitive composite scores were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Self-reported level of fatigue, an aspect of medical burden, was associated with cognitive performance in the domain of attention in a sample of MS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/arclin\/acaf074","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T11:34:25Z","timestamp":1753788865000},"source":"Crossref","is-referenced-by-count":0,"title":["Self-Reported Fatigue Levels Predict Performance on Attention Measures in Multiple Sclerosis"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7842-5171","authenticated-orcid":false,"given":"Deanna","family":"Eilenberger","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University , Providence, RI ,","place":["USA"]},{"name":"Department of Psychiatry and Behavioral Health, Brown University Health , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-4898","authenticated-orcid":false,"given":"Laura E","family":"Korthauer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University , Providence, RI ,","place":["USA"]},{"name":"Department of Psychiatry and Behavioral Health, Brown University Health , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cahill","sequence":"additional","affiliation":[{"name":"Department of Neurology, Warren Alpert Medical School of Brown University , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Department of Neurology, Warren Alpert Medical School of Brown University , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Pillemer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University , Providence, RI ,","place":["USA"]},{"name":"Department of Psychiatry and Behavioral Health, Brown University Health , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"10","key":"2026020509515534900_ref1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1586\/14737175.8.10.1585","article-title":"Cognitive changes in multiple sclerosis","volume":"8","author":"Amato","year":"2008","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"4","key":"2026020509515534900_ref2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1037\/0894-4105.11.4.535","article-title":"Executive functions in multiple sclerosis: An analysis of temporal ordering, semantic encoding, and planning abilities","volume":"11","author":"Arnett","year":"1997","journal-title":"Neuropsychology"},{"key":"2026020509515534900_ref3","volume-title":"Beck depression inventory","author":"Beck","year":"1996","edition":"2nd"},{"issue":"01","key":"2026020509515534900_ref4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4274\/Tnd.15045","article-title":"Determining the frequency of depression and cognitive dysfunction in patients with multiple sclerosis","volume":"19","author":"Bilgi","year":"2013","journal-title":"T\u00fcrk n\u00f6roloji dergisi"},{"key":"2026020509515534900_ref5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"key":"2026020509515534900_ref6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fneur.2019.00261","article-title":"Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes","volume":"10","author":"Brochet","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"12","key":"2026020509515534900_ref7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurology"},{"issue":"11","key":"2026020509515534900_ref8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/WNL.0b013e3182698da3","article-title":"Looking anew at cognitive dysfunction in multiple sclerosis: The gorilla in the room","volume":"79","author":"Feinstein","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"2026020509515534900_ref9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1590\/s0004-282x2010000400029","article-title":"Cognitive deficits in multiple sclerosis: A systematic review","volume":"68","author":"Ferreira","year":"2010","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"1","key":"2026020509515534900_ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2016.4867","article-title":"Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell Journal"},{"key":"2026020509515534900_ref11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jad.2018.07.038","article-title":"Clinical utility of the 15-item geriatric depression scale (GDS-15) for use with young and middle-aged adults","volume":"241","author":"Guerin","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"2026020509515534900_ref12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1352458506071161","article-title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","volume":"13","author":"Korostil","year":"2007","journal-title":"Multiple Sclerosis"},{"issue":"10","key":"2026020509515534900_ref13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1177\/1352458519860319","article-title":"Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis","volume":"26","author":"Leavitt","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"2026020509515534900_ref14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archneur.1990.00530010124031","article-title":"Affective disorders in multiple sclerosis. Review and recommendations for clinical research","volume":"47","author":"Minden","year":"1990","journal-title":"Archives of Neurology"},{"issue":"2","key":"2026020509515534900_ref15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.neuropsych.15070167","article-title":"Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS","volume":"28","author":"Morrow","year":"2016","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"2026020509515534900_ref16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.18502\/cjn.v21i3.11106","article-title":"Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study","volume":"21","author":"Nabizadeh","year":"2022","journal-title":"Current Journal of Neurology"},{"issue":"6","key":"2026020509515534900_ref17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Annals of Neurology"},{"issue":"1\u20132","key":"2026020509515534900_ref18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.10.002","article-title":"Cognitive impairment in different MS subtypes and clinically isolated syndromes","volume":"267","author":"Potagas","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"2026020509515534900_ref19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/wnl.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"issue":"5","key":"2026020509515534900_ref20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1212\/wnl.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"2026020509515534900_ref21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.msard.2014.01.003","article-title":"Cognitive performance profile in different phenotypes of MS with cognitive complaints","volume":"3","author":"Rosti-Otajarvi","year":"2014","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"4","key":"2026020509515534900_ref22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: A review","volume":"76","author":"Siegert","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"2026020509515534900_ref23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.30773\/pi.2019.0106","article-title":"Neuropsychiatric symptoms of multiple sclerosis: State of the art","volume":"16","author":"Silveira","year":"2019","journal-title":"Psychiatry Investigation"},{"key":"2026020509515534900_ref24","volume-title":"MSVirtual 2020, the 8th Joint ACTRIMS-ECTRIMS Meeting, September 11-13, 2020","author":"Thelen"},{"issue":"3","key":"2026020509515534900_ref25","first-page":"239","article-title":"Polypharmacy in multiple sclerosis: Current knowledge and future directions","volume":"118","author":"Thelen","year":"2021","journal-title":"Missouri Medicine"},{"issue":"5","key":"2026020509515534900_ref26","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1212\/WNL.0000000000006854","article-title":"Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders","volume":"92","author":"Whitehouse","year":"2019","journal-title":"Neurology"}],"container-title":["Archives of Clinical Neuropsychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/41\/1\/acaf074\/64054733\/acaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/41\/1\/acaf074\/64054733\/acaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:52:03Z","timestamp":1770303123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/acn\/article\/doi\/10.1093\/arclin\/acaf074\/8235624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/arclin\/acaf074","relation":{},"ISSN":["1873-5843"],"issn-type":[{"value":"1873-5843","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,8,15]]},"article-number":"acaf074"}}